The new way prosecutors are using an old act
And how it's affecting drug CEOs
[jwp-video n="1"]
As the effects of the opioid crisis are felt across the country, federal prosecutors are taking action and prosecuting CEOs of pharmaceutical companies. The Controlled Substance Act is one of their most novel weapons.
Watch as CQ Roll Call’s senior multimedia producer Jinitzail Hernández explains how.
[jwp-video n=”1″]
